Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
215.28 USD | +0.13% | -0.75% | +5.07% |
11:36am | ANALYST RECOMMENDATIONS : Adobe, AMD, Apple, Costco, HP, Snap... | ![]() |
Dec. 07 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
Business Summary
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Number of employees : 87,000
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Research and Development Solutions
55.0
%
| 7,556 | 54.5 % | 7,921 | 55.0 % | +4.83% |
Technology and Analytics Solutions
39.9
%
| 5,534 | 39.9 % | 5,746 | 39.9 % | +3.83% |
Contract Sales and Medical Solutions
5.2
%
| 784 | 5.7 % | 743 | 5.2 % | -5.23% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
42.0
%
| 4,717 | 34.0 % | 6,052 | 42.0 % | +28.30% |
Europe and Africa
30.3
%
| 4,357 | 31.4 % | 4,366 | 30.3 % | +0.21% |
Asia-Pacific
20.8
%
| 2,669 | 19.2 % | 2,996 | 20.8 % | +12.25% |
Americas
6.9
%
| 2,131 | 15.4 % | 996 | 6.9 % | -53.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 61 | 2016 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 62 | 2020 |
James Berkshire
COO | Chief Operating Officer | 50 | 2017 |
Jeffrey Spaeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Karl Guenault
CTO | Chief Tech/Sci/R&D Officer | - | 2017 |
W. Staub
CTO | Chief Tech/Sci/R&D Officer | 60 | 2016 |
Nick Childs
IRC | Investor Relations Contact | - | 2021 |
Comptroller/Controller/Auditor | 39 | 2019 | |
Corporate Officer/Principal | 44 | - | |
Michael Stibilj
PRN | Corporate Officer/Principal | 54 | 2017 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Danhakl
BRD | Director/Board Member | 67 | 2016 |
Colleen Goggins
BRD | Director/Board Member | 68 | 2017 |
Ari Bousbib
CEO | Chief Executive Officer | 61 | 2016 |
John Connaughton
BRD | Director/Board Member | 57 | 2007 |
Jim Fasano
BRD | Director/Board Member | 53 | 2016 |
John Leonard
BRD | Director/Board Member | 65 | 2015 |
Todd Sisitsky
BRD | Director/Board Member | 51 | 2015 |
Carol Burt
BRD | Director/Board Member | 65 | 2019 |
Sheila Stamps
BRD | Director/Board Member | 65 | 2022 |
Director/Board Member | 52 | 2022 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 257,100,000 | 180,494,649 ( 70.20 %) | 74,600,000 ( 29.02 %) | 70.20 % |
Company contact information

Group companies
Name | Category and Sector |
---|---|
IQVIA, Inc.
|
Technology Services - Data Processing Services
|
IQVIA Consulting & Information Services India Pvt Ltd.
|
Commercial Services - Miscellaneous Commercial Services
|
Quintiles Phase One Clinical Trials India Pvt Ltd.
|
-
|
IMS Software Services Ltd.
|
-
|
IQVIA AG (Basal Branch)
|
Technology Services - Data Processing Services
|
IMS Health BVBA
|
-
|
IMS Health Analytics Services Pvt Ltd.
|
Commercial Services - Miscellaneous Commercial Services
|
IMS Health Information Solutions India Pvt Ltd.
|
Commercial Services - Miscellaneous Commercial Services
|
Q Squared Solutions (India) Pvt Ltd.
|
Commercial Services - Miscellaneous Commercial Services
|
Sector
Sales per Business
Sales per region
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
BUY
Number of Analysts
21
Last Close Price
215.28USD
Average target price
230.52USD
Spread / Average Target
+7.08%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.07% | 39 289 M $ | |
+70.40% | 41 313 M $ | |
-55.28% | 30 625 M $ | |
-28.65% | 27 758 M $ | |
+40.26% | 22 431 M $ | |
-28.45% | 21 339 M $ | |
+4.49% | 17 693 M $ | |
-13.10% | 11 356 M $ | |
-17.58% | 10 803 M $ | |
-6.17% | 10 488 M $ |
- Stock
- Equities
- Stock Iqvia Holdings Inc. - Nyse
- Company Iqvia Holdings Inc.